CFO
TMDX icon

CVA Family Office’s Transmedics TMDX Stock Holding History

CVA Family Office’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$994 Buy
+10
New +$1.3K ﹤0.01% 1651

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVA Family Office's TMDX Position: Q1 2026 in Review

CVA Family Office opened a new position in Transmedics (TMDX) in Q1 2026: 10 shares worth $994. The stake represents ﹤0.01% of the portfolio and ranks #1651 among its holdings.

414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • CVA Family Office held 10 shares of Transmedics worth $994 as of Q1 2026.
  • Transmedics was a new CVA Family Office position in Q1 2026.
  • Transmedics made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1651 holding.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.